221 related articles for article (PubMed ID: 35398108)
21. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States.
Karkare S; Zhdanava M; Pilon D; Nash AI; Morrison L; Shah A; Lefebvre P; Joshi K
Clin Ther; 2022 Nov; 44(11):1432-1448. PubMed ID: 36207167
[TBL] [Abstract][Full Text] [Related]
23. Cause-specific life years lost in individuals with treatment-resistant depression: A Danish nationwide register-based cohort study.
Madsen KB; Plana-Ripoll O; Musliner KL; Debost JP; Petersen LV; Munk-Olsen T
J Affect Disord; 2021 Feb; 280(Pt A):250-257. PubMed ID: 33220561
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of pharmaceutically treated depression and treatment resistant depression in Taiwan.
Fife D; Feng Y; Wang MY; Chang CJ; Liu CY; Juang HT; Furnback W; Singh J; Wang B
Psychiatry Res; 2017 Jun; 252():277-283. PubMed ID: 28288438
[TBL] [Abstract][Full Text] [Related]
25. Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.
Cepeda MS; Reps J; Fife D; Blacketer C; Stang P; Ryan P
Depress Anxiety; 2018 Mar; 35(3):220-228. PubMed ID: 29244906
[TBL] [Abstract][Full Text] [Related]
26. Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study.
Brenner P; Nygren A; Hägg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Int J Psychiatry Clin Pract; 2022 Sep; 26(3):251-258. PubMed ID: 34851214
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression.
Zhdanava M; Karkare S; Pilon D; Joshi K; Rossi C; Morrison L; Sheehan J; Lefebvre P; Lopena O; Citrome L
Adv Ther; 2021 Sep; 38(9):4900-4916. PubMed ID: 34368919
[TBL] [Abstract][Full Text] [Related]
28. Real-world use of pharmacological treatments for incident bipolar disorder: A Finnish nationwide cohort study.
Koistinaho A; Poranen J; Tanskanen A; Tiihonen J; Taipale H; Lähteenvuo M
J Affect Disord; 2023 Nov; 340():237-244. PubMed ID: 37557987
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression.
Gobbi G; Ghabrash MF; Nuñez N; Tabaka J; Di Sante J; Saint-Laurent M; Vida S; Kolivakis T; Low N; Cervantes P; Booij L; Comai S
Int Clin Psychopharmacol; 2018 Jan; 33(1):34-43. PubMed ID: 28906325
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.
Adekkanattu P; Olfson M; Susser LC; Patra B; Vekaria V; Coombes BJ; Lepow L; Fennessy B; Charney A; Ryu E; Miller KD; Pan L; Yangchen T; Talati A; Wickramaratne P; Weissman M; Mann J; Biernacka JM; Pathak J
J Affect Disord; 2023 Mar; 324():102-113. PubMed ID: 36529406
[TBL] [Abstract][Full Text] [Related]
32. Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics.
Klein N; Sacher J; Wallner H; Tauscher J; Kasper S
CNS Spectr; 2004 Nov; 9(11):823-32. PubMed ID: 15520606
[TBL] [Abstract][Full Text] [Related]
33. The prevalence and economic burden of treatment-resistant depression in Thailand.
Prasartpornsirichoke J; Pityaratstian N; Poolvoralaks C; Sirinimnualkul N; Ormtavesub T; Hiranwattana N; Phonsit S; Rungnirundorn T
BMC Public Health; 2023 Aug; 23(1):1541. PubMed ID: 37573321
[TBL] [Abstract][Full Text] [Related]
34. Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.
Hassan AK; Farmer KC; Brahm NC; Neas BR
Int J Clin Pharm; 2016 Apr; 38(2):429-37. PubMed ID: 26935957
[TBL] [Abstract][Full Text] [Related]
35. Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants.
Park H; Park CM; Woo JM; Shin JY; Lee EK; Kwon SH
J Med Econ; 2021; 24(1):589-597. PubMed ID: 33879031
[TBL] [Abstract][Full Text] [Related]
36. Economic burden of treatment-resistant depression among veterans in the United States.
Szukis H; Joshi K; Huang A; Amos TB; Wang L; Benson CJ
Curr Med Res Opin; 2021 Aug; 37(8):1393-1401. PubMed ID: 33879005
[TBL] [Abstract][Full Text] [Related]
37. Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression.
Bhowmik D; Aparasu RR; Rajan SS; Sherer JT; Ochoa-Perez M; Chen H
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):551-61. PubMed ID: 25470655
[TBL] [Abstract][Full Text] [Related]
38. Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.
Jensen KJ; Gronemann FH; Ankarfeldt MZ; Jimenez-Solem E; Alulis S; Riise J; Bødker N; Osler M; Petersen J
PLoS One; 2022; 17(9):e0275299. PubMed ID: 36166443
[TBL] [Abstract][Full Text] [Related]
39. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
[No Abstract] [Full Text] [Related]
40. Treatment resistant depression incidence and prevalence using the French nationwide claims database.
Bosco-Lévy P; Grelaud A; Blin P; Astruc B; Falissard B; Llorca PM; Bernard MA; Lassalle R; Moore N; Droz-Perroteau C
Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):169-177. PubMed ID: 32767421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
